Navigation Links
Escalon(R) Announces Promotion of Industry Veteran Barry Durante to President of Sonomed, Inc.
Date:11/9/2007

Sonomed to Showcase Product Portfolio at the American Academy of

Ophthalmology Annual Meeting

WAYNE, Pa., Nov. 9 /PRNewswire-FirstCall/ -- Escalon Medical Corp. (Nasdaq Capital Market: ESMC) today announced the promotion of Mr. Barry Durante to President of Sonomed, a wholly-owned subsidiary of Escalon and a worldwide leader in ophthalmic ultrasound. In his new role he will be responsible for Sonomed's entire operations, while leading the company's technology and product development strategies. Mr. Durante joined Sonomed in 1988 and has served in numerous management positions, most recently as Executive Vice President.

Richard J. DePiano Jr., Escalon's Chief Operating Officer, commented, "Barry has played an important role in Sonomed's growth and development and we believe this is a natural transition. Over the past two decades he has been successful in growing sales on a consistent basis while exceeding customer expectations. His vast experience in dealing with both domestic and international distribution networks will be most beneficial as we continue to implement targeted growth strategies."

Sonomed will showcase its industry-leading product portfolio at the American Academy of Ophthalmology Annual Meeting, November 10 - 13, 2007, in New Orleans, LA. Sonomed develops, manufactures and markets ultrasound systems for diagnostic and biometric applications in ophthalmology. The systems are of four types: A-Scans, B-Scans, High Frequency B-Scans ("UBMs") and pachymeters.

Prior to joining Sonomed, Mr. Durante was with Sonometrics Incorporated, an ophthalmic ultrasound manufacturer and Ocusery, Inc., an ophthalmic mobile services company.

Founded in 1987, Escalon develops markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. Drew, which operates as a separate business unit, provides instrumentation and consumables for the diagnosis and moni
'/>"/>

SOURCE Escalon Medical Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FALLS, N.Y., Jan. 15, 2014   Niagara Thermal ... been selected by Buffalo BioBlower Technologies LLC ("B3") as ... SBIR Phase 2 award from the Army Corps of ... system that kills all biological contaminants and destroys VOCs ...
(Date:1/15/2014)... and SAN JOSE, California , January ... company developing antibody-drug conjugates for cancer, today announced the appointment ... Directors. Dr Reynolds has over 20 years, development experience gained ... at Seattle Genetics. "I am delighted to welcome ...
(Date:1/15/2014)... , January 15, 2014 A study has ... on the Formula 1 track could help to tackle the ... Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) and ... provider Simplyhealth. Telemetry technology, which is inspired by ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... latent viruses is the Epstein Barr Virus (EBV), and one ... is a chronic inflammatory disease that destroys the body’s joints. ... patients have high concentrations of EBV DNA in their bodies ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), today announced ... at 9:00 a.m. Eastern Time on Thursday,November 15, 2007 ... Flavin, Ph.D., Chairman & Chief Executive Officer, and other,members ... on the Company.,A press release reporting the third quarter ...
... Genasense Plus Temodar(R) and Abraxane(R) Show Promising Early Clinical ... ... Activity, BERKELEY HEIGHTS, N.J., Nov. 8 Genta,Incorporated (Nasdaq: ... the Company,s lead oncology drug, Genasense(R) (oblimersen,sodium) Injection in combination ...
... Inc.,(Nasdaq: MEDX ) today announced that Marc Rubin, ... to serve as a director on Medarex,s Board,effective November ... of Titan Pharmaceutical, Inc., a,biopharmaceutical company publicly traded on ... 2007, he was Head of Global Research and,Development for ...
Cached Biology Technology:Advanced Life Sciences to Host Third Quarter 2007 Financial Results Conference Call and Live Webcast 2Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 2Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 3Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 4Medarex Announces Election of Marc Rubin as New Board Member 2
(Date:4/17/2014)... study suggests that fish consumption advisories for expecting ... long-lived contaminants like persistent organic pollutants (POPs). ... researchers including University of Toronto Scarborough PhD student ... how different levels of environmental contamination, a mother,s ... in the body influenced exposure in her children. ...
(Date:4/17/2014)... credit-card-sized anthrax detection cartridge developed at Sandia National Laboratories ... safer, easier, faster and cheaper. , Bacillus ... found in soils all over the world and can ... and animals. The bacteria can survive in harsh conditions ... may occur through skin contact, inhalation of spores ...
(Date:4/17/2014)... in German . ... they also provide us with a continuous stream of information ... or sit still in a car the world glides ... retinas. Seemingly without effort, our brain calculates self-motion from this ... and a steady gaze during our own movements. Together with ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4
... to avoid smiling in public in order to hide their ... costly treatment options, such as veneers, crowns and bonding, served ... such stains and boost their self-esteem. , However, Kim ... how a new tooth whitening procedure he used on a ...
... women, accumulated sun exposure has already permanently damaged their ... up as unsightly dark splotches and uneven skin tone ... a compound best known for treating arthritis ?can actually ... help fade existing ones. , "These findings on glucosamine ...
... In a paper being presented in two American ... joint Estonian-French team demonstrated "for the first time ... suggesting that mitochondria may mechanically regulate nuclear function." ... over 10 years, reported that it recently "found ...
Cached Biology News:Tetracycline plus teeth equal gray smile 2Tetracycline plus teeth equal gray smile 3Science finds new fix for UV-damaged skin in arthritis treatment 2Science finds new fix for UV-damaged skin in arthritis treatment 3First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 2First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 3
...
... Hormone Receptor 2 ( Abpromise ... Antigen: Synthetic peptide: AFRHCNPNGTWDFMHSLN, ... of Human Parathyroid Hormone Receptor 2 ... 5746 Swiss ...
... pan B (B220), 4.5 m, coated ... efficient positive isolation or depletion of ... or lymph node cell suspensions. B220 ... cells and lytically active subsets of ...
POU domain, class 2, transcription factor 2,...
Biology Products: